Dr. Michael N. Desvigne, MD

Dr. Desvigne practices at Abrazo Arrowhead Campus in Glendale, Arizona, part of Tenet Healthcare.

Dr. Desvigne's NPI, 1356336317, was assigned on September 15, 2005. Dr. Desvigne graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1989. Dr. Desvigne holds Arizona license 35062.

Dr. Desvigne's primary practice is Abrazo Arrowhead Campus, at 18701 North 67th Avenue, Glendale, AZ 85308 in Maricopa County. The practice phone is (623) 561-1000.

Dr. Desvigne's primary practice is Abrazo Arrowhead Campus in Glendale, Arizona, part of Tenet Healthcare. Dr. Desvigne is also affiliated with Encompass Health Valley of The Sun Rehabilitation Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Desvigne to 5 more medical groups, 4 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desvigne practices, 7 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Desvigne's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Desvigne is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Desvigne's licenses on file in 7 states: Arizona, Colorado, California, Hawaii, New Mexico, West Virginia and Maryland.

Dmand AI lists removal of damaged skin or skin graft among the conditions Dr. Desvigne treats.

CMS data shows 83 Medicare services from Dr. Desvigne across 3 procedure codes in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $5,190 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Desvigne in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 71% have arthritis. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Desvigne's median patient age at 66, with 50% women.

In 2024, Dr. Desvigne wrote 117 Medicare Part D claims for 29 patients. 87% of them were for generic drugs. CMS names the drug for 70 of them, across 4 drugs with 11 or more claims each, at $18,674 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

Dr. Desvigne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 66 procedures of removal of tissue by Dr. Desvigne, more than 81% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Desvigne in 2018. The most frequent topics are Negative-Pressure Wound Therapy, Wound Healing and Wounds and Injuries. Dr. Desvigne has published most often in Wounds. Dr. Desvigne's most frequent co-authors are Mark D. Suski, MD, Abigail E. Chaffin, MD and William Harmon Tettelbach, MD.

CMS Open Payments shows 2,748 general payments to Dr. Desvigne from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Musculoskeletal Transplant Foundation Inc. paid the most, $1,161,823. It also lists 1 research payment totaling $35,120 in 2019.

Dmand AI lists 2 awards for Dr. Desvigne, most recently Top Doctors:Arizona State in 2013.

Dr. Desvigne graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1989. Dr. Desvigne is a member of ACS and ASPS.

Dr. Desvigne is in network with 4 carriers, including Aetna, Cigna and Humana. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.